DK0730465T3 - Anvendelse af angiotensin III og analoger dertil til vævsreparation - Google Patents

Anvendelse af angiotensin III og analoger dertil til vævsreparation

Info

Publication number: DK0730465T3
Authority: DK; Denmark
Prior art keywords: analogues; angiotensin iii; tissue repair; wound healing; analogs
Prior art date: 1993-09-24

Application number

DK94928150T

Other languages

Danish (da)

English (en)

Inventor

Gere Stodder Dizerega

Kathleen Elizabeth Rodgers

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2002-04-08

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2002-04-08 Application granted granted Critical

2002-04-08 Publication of DK0730465T3 publication Critical patent/DK0730465T3/da

Links

QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 title abstract 2
101800000738 Angiotensin-3 Proteins 0.000 title abstract 2
102400000348 Angiotensin-3 Human genes 0.000 title abstract 2
230000017423 tissue regeneration Effects 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK94928150T 1993-09-24 1994-09-19 Anvendelse af angiotensin III og analoger dertil til vævsreparation DK0730465T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24
PCT/US1994/010503 WO1995008337A1 (en)	1993-09-24	1994-09-19	Use of angiotensin iii and analogs thereof in tissue repair

Publications (1)

Publication Number	Publication Date
DK0730465T3 true DK0730465T3 (da)	2002-04-08

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94928150T DK0730465T3 (da)	1993-09-24	1994-09-19	Anvendelse af angiotensin III og analoger dertil til vævsreparation

Country Status (13)

Country	Link
US (1)	US5629292A (de)
EP (1)	EP0730465B1 (de)
JP (1)	JPH09502977A (de)
AT (1)	ATE210677T1 (de)
AU (1)	AU706333B2 (de)
CA (1)	CA2172493C (de)
DE (1)	DE69429450T2 (de)
DK (1)	DK0730465T3 (de)
ES (1)	ES2168312T3 (de)
PT (1)	PT730465E (de)
TW (1)	TW311088B (de)
WO (1)	WO1995008337A1 (de)
ZA (1)	ZA947338B (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en)	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
EP1410801B1 (de)	1997-01-28	2013-04-10	University Of Southern California	Verfahren zur Förderung der hämatopoietischen Zellproliferation und Differenzierung
AU6650098A (en) *	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
EP1047441A1 (de) *	1997-11-26	2000-11-02	University Of Southern California	Verfahren zur förderung der proliferation und differenzierung von hämatopoietischen und mesenchymalen zellen
CA2315266C (en)	1997-12-12	2004-08-10	University Of Southern California	Wound healing compositions
JP2002509077A (ja)	1998-02-09	2002-03-26	ユニヴァースティオブサザーンカリフォルニア	赤血球形成促進方法
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
AU3077299A (en)	1998-03-11	1999-09-27	University Of Southern California	Method of promoting production of living tissue equivalents
AU752041B2 (en) *	1998-04-09	2002-09-05	University Of Southern California	Methods for treatment and prevention of infections
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
AU759285B2 (en)	1998-05-11	2003-04-10	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
DE69911609T2 (de)	1998-07-13	2004-07-01	University Of Southern California, Los Angeles	Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
DE60017211T2 (de)	1999-02-17	2005-06-02	Pfizer Products Inc., Groton	Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en) *	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
WO2002043731A2 (en)	2000-11-30	2002-06-06	University Of Florida	Treatments for neurogenetic disorders, impulse control disorders, and wound healing
US7122523B2 (en) *	2001-05-01	2006-10-17	University Of Southern California	Methods for inhibiting tumor cell proliferation
AU2008303955A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of Pseudomonas aeruginosa infection
WO2009043441A1 (en) *	2007-09-11	2009-04-09	Mondobiotech Laboratories Ag	D-ala-gln-octadecyl ester as a therapeutic agent
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009039983A2 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
JP5385283B2 (ja) *	2007-09-11	2014-01-08	モンドバイオテックラボラトリーズアクチエンゲゼルシャフト	治療剤としてのウロコルチンおよび副腎皮質刺激ホルモン放出因子の使用
US20090227507A1 (en) *	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
HUE026131T2 (en)	2008-12-29	2016-05-30	Trevena Inc	Beta-arresin effector and preparations and methods for their use
EP2536422B8 (de)	2011-02-02	2023-06-21	University of Southern California	Verfahren zur behandlung von diabetischen fussgeschwüren
CN104168907A (zh)	2012-01-31	2014-11-26	特维娜有限公司	β-抑制蛋白效应器及其组合物与使用方法
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
AU2014284496A1 (en)	2013-07-03	2016-01-21	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Method for treating cognitive dysfunction
CA2938986A1 (en)	2014-02-07	2015-08-13	Trevena, Inc.	Crystalline and amorphous forms of a beta-arrestin effector
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
US9611293B2 (en)	2014-05-19	2017-04-04	Trevena, Inc.	Synthesis of beta-arrestin effectors
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
EP3171886A4 (de)	2014-07-21	2018-01-24	The Arizona Board of Regents On Behalf of the University of Arizona	Ang-(1-7)derivat-oligopeptide und verfahren zur verwendung und herstellung davon
MA43230A (fr) *	2015-10-14	2021-04-14	Tarix Pharmaceuticals Ltd	Méthodes et compositions pour le traitement d'une épidermolyse bulleuse

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en not_active Ceased
- 1994-09-19 EP EP94928150A patent/EP0730465B1/de not_active Expired - Lifetime
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AU706333B2 (en)	1999-06-17
EP0730465A1 (de)	1996-09-11
PT730465E (pt)	2002-06-28
CA2172493A1 (en)	1995-03-30
CA2172493C (en)	2003-09-16
US5629292A (en)	1997-05-13
ES2168312T3 (es)	2002-06-16
AU7730294A (en)	1995-04-10
TW311088B (de)	1997-07-21
DE69429450D1 (de)	2002-01-24
DE69429450T2 (de)	2002-07-25
EP0730465B1 (de)	2001-12-12
EP0730465A4 (de)	1997-11-12
JPH09502977A (ja)	1997-03-25
ATE210677T1 (de)	2001-12-15
WO1995008337A1 (en)	1995-03-30
ZA947338B (en)	1995-05-10

Publication	Publication Date	Title
EP0730465A4 (de)	1997-11-12	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de)	2010-08-26	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
ATE268782T1 (de)	2004-06-15	Zusammensetzungen zur wundheilung
ES2154650T3 (es)	2001-04-16	Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador.
DK0785948T3 (da)	2003-08-04	Analoger af keratinocyt vækstfaktor
DK0759687T3 (da)	1999-05-17	Anvendelse af gelpræparater som bejdsemidler
NO991302L (no)	1999-03-17	Munnvask-sammensetninger
ATE423562T1 (de)	2009-03-15	Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
ES2221950T3 (es)	2005-01-16	Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
BR0111678A (pt)	2003-06-03	Composições medicinais contendo derivados de propenona
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
ATE172108T1 (de)	1998-10-15	Verwendung von diglycerinestern gegen unreine haut
ES2093944T3 (es)	1997-01-01	Composicion cosmetica y/o dermatologica de accion despigmentante que contiene un acido di- o tri-cafeoilquinico o una mezcla de estos.
GR1001067B (el)	1993-04-28	Νέες κτηνιατρικές και προστι?έμενες συν?έσεις προστασίας φυτών.
NO982229D0 (no)	1998-05-15	Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
ECSP003859A (es)	2002-09-27	Composicion para el tratamiento de tejidos dañados
ES2121109T3 (es)	1998-11-16	Composicion de champu.
SE0000307D0 (sv)	2000-01-31	Method and formulation för treatment of vasoconstriction
NO20022000L (no)	2002-06-27	6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
DE69824862D1 (de)	2004-08-05	Zusammenstellungen zur verbesserten wundheilung
IT1265647B1 (it)	1996-11-22	Composizione farmaceutiche topiche per le allergie respiratorie
ATE306929T1 (de)	2005-11-15	Inositolphosphoglycan und ribose zur behandlung von ischämischen-reperfusionschaden